Clinical Trial Update: MR-Linac Guided Adaptive FSRT for Brain Metastases From Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating MR-Linac guided adaptive FSRT for brain metastases in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED